Literature DB >> 33511102

Structural Insight Into the SARS-CoV-2 Nucleocapsid Protein C-Terminal Domain Reveals a Novel Recognition Mechanism for Viral Transcriptional Regulatory Sequences.

Mei Yang1,2, Suhua He1, Xiaoxue Chen1, Zhaoxia Huang1, Ziliang Zhou1, Zhechong Zhou1, Qiuyue Chen1, Shoudeng Chen1,2, Sisi Kang1,2.   

Abstract

Coronavirus disease 2019 (n class="Disease">COVID-19) has caused massive disruptions to society and the economy, and the transcriptional regulatory mechanisms behind the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are poorly understood. Herein, we determined the crystal structure of the SARS-CoV-2 nucleocapsid protein C-terminal domain (CTD) at a resolution of 2.0 Å, and demonstrated that the CTD has a comparable distinct electrostatic potential surface to equivalent domains of other reported CoVs, suggesting that the CTD has novel roles in viral RNA binding and transcriptional regulation. Further in vitro biochemical assays demonstrated that the viral genomic intergenic transcriptional regulatory sequences (TRSs) interact with the SARS-CoV-2 nucleocapsid protein CTD with a flanking region. The unpaired adeno dinucleotide in the TRS stem-loop structure is a major determining factor for their interactions. Taken together, these results suggested that the nucleocapsid protein CTD is responsible for the discontinuous viral transcription mechanism by recognizing the different patterns of viral TRS during transcription.
Copyright © 2021 Yang, He, Chen, Huang, Zhou, Zhou, Chen, Chen and Kang.

Entities:  

Keywords:  C terminal domain; COVID-19; SARS-CoV-2; coronavirus; crystal structure; nucleocapsid protein; transcription regulating sequences

Year:  2021        PMID: 33511102      PMCID: PMC7835709          DOI: 10.3389/fchem.2020.624765

Source DB:  PubMed          Journal:  Front Chem        ISSN: 2296-2646            Impact factor:   5.221


  39 in total

1.  Improved R-factors for diffraction data analysis in macromolecular crystallography.

Authors:  K Diederichs; P A Karplus
Journal:  Nat Struct Biol       Date:  1997-04

2.  X-ray structures of the N- and C-terminal domains of a coronavirus nucleocapsid protein: implications for nucleocapsid formation.

Authors:  Hariharan Jayaram; Hui Fan; Brian R Bowman; Amy Ooi; Jyothi Jayaram; Ellen W Collisson; Julien Lescar; B V Venkataram Prasad
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

3.  Structural Characterization of Human Coronavirus NL63 N Protein.

Authors:  Bozena Szelazek; Wojciech Kabala; Krzysztof Kus; Michal Zdzalik; Aleksandra Twarda-Clapa; Przemyslaw Golik; Michal Burmistrz; Dominik Florek; Benedykt Wladyka; Krzysztof Pyrc; Grzegorz Dubin
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

4.  Carboxyl terminus of severe acute respiratory syndrome coronavirus nucleocapsid protein: self-association analysis and nucleic acid binding characterization.

Authors:  Haibin Luo; Jing Chen; Kaixian Chen; Xu Shen; Hualiang Jiang
Journal:  Biochemistry       Date:  2006-10-03       Impact factor: 3.162

5.  Coronavirus nucleocapsid protein facilitates template switching and is required for efficient transcription.

Authors:  Sonia Zúñiga; Jazmina L G Cruz; Isabel Sola; Pedro A Mateos-Gómez; Lorena Palacio; Luis Enjuanes
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

Review 6.  The Nonstructural Proteins Directing Coronavirus RNA Synthesis and Processing.

Authors:  E J Snijder; E Decroly; J Ziebuhr
Journal:  Adv Virus Res       Date:  2016-09-14       Impact factor: 9.937

7.  Structures of the N- and C-terminal domains of MHV-A59 nucleocapsid protein corroborate a conserved RNA-protein binding mechanism in coronavirus.

Authors:  Yanlin Ma; Xiaohang Tong; Xiaoling Xu; Xuemei Li; Zhiyong Lou; Zihe Rao
Journal:  Protein Cell       Date:  2010-07-29       Impact factor: 14.870

8.  Nucleocapsid protein-dependent assembly of the RNA packaging signal of Middle East respiratory syndrome coronavirus.

Authors:  Wei-Chen Hsin; Chan-Hua Chang; Chi-You Chang; Wei-Hao Peng; Chung-Liang Chien; Ming-Fu Chang; Shin C Chang
Journal:  J Biomed Sci       Date:  2018-05-24       Impact factor: 8.410

9.  Transient oligomerization of the SARS-CoV N protein--implication for virus ribonucleoprotein packaging.

Authors:  Chung-ke Chang; Chia-Min Michael Chen; Ming-hui Chiang; Yen-lan Hsu; Tai-huang Huang
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

10.  Solution structure of the c-terminal dimerization domain of SARS coronavirus nucleocapsid protein solved by the SAIL-NMR method.

Authors:  Mitsuhiro Takeda; Chung-ke Chang; Teppei Ikeya; Peter Güntert; Yuan-hsiang Chang; Yen-lan Hsu; Tai-huang Huang; Masatsune Kainosho
Journal:  J Mol Biol       Date:  2007-12-05       Impact factor: 5.469

View more
  22 in total

1.  Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals.

Authors:  Willem A Mak; Johannes G M Koeleman; David S Y Ong
Journal:  J Clin Virol       Date:  2022-04-12       Impact factor: 14.481

Review 2.  Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19).

Authors:  Monic Andrew; Gurunathan Jayaraman
Journal:  Carbohydr Res       Date:  2021-05-03       Impact factor: 2.975

3.  Insights into the specificity for the interaction of the promiscuous SARS-CoV-2 nucleocapsid protein N-terminal domain with deoxyribonucleic acids.

Authors:  Icaro Putinhon Caruso; Vitor Dos Santos Almeida; Mariana Juliani do Amaral; Guilherme Caldas de Andrade; Gabriela Rocha de Araújo; Talita Stelling de Araújo; Jéssica Moreira de Azevedo; Glauce Moreno Barbosa; Leonardo Bartkevihi; Peter Reis Bezerra; Katia Maria Dos Santos Cabral; Isabella Otênio de Lourenço; Clara L F Malizia-Motta; Aline de Luna Marques; Nathane Cunha Mebus-Antunes; Thais Cristtina Neves-Martins; Jéssica Maróstica de Sá; Karoline Sanches; Marcos Caique Santana-Silva; Ariana Azevedo Vasconcelos; Marcius da Silva Almeida; Gisele Cardoso de Amorim; Cristiane Dinis Anobom; Andrea T Da Poian; Francisco Gomes-Neto; Anderson S Pinheiro; Fabio C L Almeida
Journal:  Int J Biol Macromol       Date:  2022-01-22       Impact factor: 8.025

4.  Discovery of new TLR7 agonists by a combination of statistical learning-based QSAR, virtual screening, and molecular dynamics.

Authors:  Ardavan Abiri; Masoud Rezaei; Mohammad Hossein Zeighami; Younes Vaezpour; Leili Dehghan; Maedeh KhorramGhahfarokhi
Journal:  Inform Med Unlocked       Date:  2021-11-15

5.  Crystal structures of the SARS-CoV-2 nucleocapsid protein C-terminal domain and development of nucleocapsid-targeting nanobodies.

Authors:  Zhenghu Jia; Chen Liu; Yuewen Chen; Heng Jiang; Zijing Wang; Jialu Yao; Jie Yang; Jiaxing Zhu; Boqing Zhang; Zhiguang Yuchi
Journal:  FEBS J       Date:  2021-10-30       Impact factor: 5.622

Review 6.  Insights into the evolutionary and prophylactic analysis of SARS-CoV-2: A review.

Authors:  Fatima Akram; Ikram Ul Haq; Amna Aqeel; Zeeshan Ahmed; Fatima Iftikhar Shah; Ali Nawaz; Javaria Zafar; Rukhma Sattar
Journal:  J Virol Methods       Date:  2021-11-24       Impact factor: 2.014

7.  Loss of Detection of sgN Precedes Viral Abridged Replication in COVID-19-Affected Patients-A Target for SARS-CoV-2 Propagation.

Authors:  Veronica Ferrucci; Pasqualino de Antonellis; Fabrizio Quarantelli; Fatemeh Asadzadeh; Francesca Bibbò; Roberto Siciliano; Carmen Sorice; Ida Pisano; Barbara Izzo; Carmela Di Domenico; Angelo Boccia; Maria Vargas; Biancamaria Pierri; Maurizio Viscardi; Sergio Brandi; Giovanna Fusco; Pellegrino Cerino; Livia De Pietro; Ciro Furfaro; Leonardo Antonio Napolitano; Giovanni Paolella; Lidia Festa; Stefania Marzinotto; Maria Concetta Conte; Ivan Gentile; Giuseppe Servillo; Francesco Curcio; Tiziana de Cristofaro; Francesco Broccolo; Ettore Capoluongo; Massimo Zollo
Journal:  Int J Mol Sci       Date:  2022-02-09       Impact factor: 5.923

8.  Detection of Anti-Nucleocapsid Antibody in COVID-19 Patients in Bangladesh Is not Correlated with Previous Dengue Infection.

Authors:  Simon D Lytton; Mahmuda Yeasmin; Asish Kumar Ghosh; Md Rakibul Hassan Bulbul; Md Maruf Ahmed Molla; Martha Herr; Helmut Duchmann; Md Mohiuddin Sharif; Tasnim Nafisa; Md Robed Amin; Nur Hosen; Md Tanvir Rahman; Sumaiya Islam; Alimul Islam; Abul Khair Mohammad Shamsuzzaman
Journal:  Pathogens       Date:  2021-05-22

Review 9.  Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19.

Authors:  Can-Rong Wu; Wan-Chao Yin; Yi Jiang; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2022-01-20       Impact factor: 7.169

10.  Dimerization of SARS-CoV-2 nucleocapsid protein affects sensitivity of ELISA based diagnostics of COVID-19.

Authors:  Wajihul Hasan Khan; Nida Khan; Avinash Mishra; Surbhi Gupta; Vikrant Bansode; Deepa Mehta; Rahul Bhambure; M Ahmad Ansari; Shukla Das; Anurag S Rathore
Journal:  Int J Biol Macromol       Date:  2022-01-17       Impact factor: 6.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.